Genome editing with engineered zinc finger nucleases.
Nat Rev Genet 11(9):636-46 (2010) PMID 20717154
Reverse genetics in model organisms such as Drosophila melanogaster, Arabidopsis thaliana, zebrafish and rats, efficient genome engineering in human embryonic stem and induced pluripotent stem cells, targeted integration in crop plants, and HIV resistance in immune cells - this broad range of outcomes has resulted from the application of the same core technology: targeted genome cleavage by engineered, sequence-specific zinc finger nucleases followed by gene modification during subsequent repair. Such 'genome editing' is now established in human cells and a number of model organisms, thus opening the door to a range of new experimental and therapeutic possibilities.
DOI: 10.1038/nrg2842Version: za2963e q8za7 q8zb9 q8zc3 q8zd8 q8ze3 q8zf0 q8zg2